Neutrophil to lymphocyte ratio is an independent prognostic factor in patients with recurrent or metastatic head and neck squamous cell cancer

Author：

Publisher： Science Publishers

ISSN： 2049-9450

Source： Molecular and Clinical Oncology, Vol.3, Iss.4, 2015-01, pp. : 839-842

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The neutrophil/lymphocyte ratio is an independent prognostic indicator in patients with bone metastasis

Oncology Letters, Vol. 2, Iss. 4, 2011-01 ,pp. : 735-740

Spandidos Publications

Access to resources Recommend Favorite

Cost‐Effectiveness of Nivolumab in Recurrent Metastatic Head and Neck Squamous Cell Carcinoma

The Oncologist, Vol. 23, Iss. 2, 2018-02 ,pp. : 225-233

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prognostic value of neutrophil-to-lymphocyte ratio in patients with glioblastoma

By Alexiou George Vartholomatos Evrysthenis Voulgaris Spyridon

Journal of Neuro-Oncology, Vol. 115, Iss. 3, 2013-12 ,pp. : 521-522

Springer Publishing Company

Access to resources Recommend Favorite

Evaluation of the Combination of Docetaxel/Carboplatin in Patients with Metastatic or Recurrent Squamous Cell Carcinoma of the Head and Neck (SCCHN): A Southwest Oncology Group Phase II Study

By Samlowski Wolfram E. Moon James Kuebler J. Philip Nichols Craig R. Gandara David R. Ozer Howard Williamson Stephen K. Atkins James N. Schuller David E. Ensley John F.

Cancer Investigation, Vol. 25, Iss. 3, 2007-04 ,pp. : 182-188

Informa Healthcare

Access to resources Recommend Favorite

Comorbidity Is a Prognostic Factor in Elderly Patients with Head and Neck Cancer

By Sanabria Alvaro Carvalho André Vartanian José Magrin José Ikeda Mauro Kowalski Luiz

Annals of Surgical Oncology, Vol. 14, Iss. 4, 2007-04 ,pp. : 1449-1457

Springer Publishing Company

Access to resources Recommend Favorite